DEVELOPMENT OF PICKERING EMULSIONS AS INJECTABLE BONE GRAFTS
DEVELOPMENT OF PICKERING EMULSIONS AS INJECTABLE BONE GRAFTS
批准号:
8581393
负责人:
Elizabeth Marie Cosgriff-Hernandez
金额:
$21.06万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2015-07-31
关键词:
ArchitectureBody TemperatureBone CementsBone GrowthBone RegenerationBone TransplantationCaringCell Differentiation processCellsCharacteristicsChemistryClinicalCuesDefectDevelopmentEmulsionsEncapsulatedExcisionFractureGenerationsGrantGrowth FactorHydrogelsHydrophobicityHydroxyapatitesIn SituInjectableInjuryInpatientsInvestigationLaboratoriesLocationMechanicsMedicalMesenchymal Stem CellsMethodologyMethodsMoldsNatural regenerationOperative Surgical ProceduresOrgan TransplantationOsteogenesisPatientsPhasePhysiologicalPolymersPorosityPropertyQuality of lifeResearchSafetyShapesSiteSurfaceTechnologyTimeTissue EngineeringTissue GraftsTissuesTranslationsTransplantationVascularizationViscosityWorkbonebone morphogenetic protein 2costimprovedin vivomusculoskeletal injurynanoparticlenovelosteoblast differentiationosteogenicpolymerizationpublic health relevancereconstructionrepairedscaffoldself assemblystatisticstissue regeneration
中文摘要
描述(申请人提供):肌肉骨骼损伤对生活质量有巨大影响,仍然是患者寻求医疗护理的主要原因之一。当传统移植无法获得或失败时,工程化组织移植具有修复受损组织的潜力。我们的实验室开发了一种新的乳液模板方法来生成用于骨再生的微孔聚合物支架。我们实验室的一个重大进步是通过开发可注射、高孔隙率的骨移植将这项技术转化为组织工程。原位固化的可注射支架可以填充不规则形状的缺陷,改善支架与周围组织之间的接触,并消除昂贵的成型技术。13,14乳液模板与当前的可注射材料相比具有几个优势,这些材料存在孔隙率低和生物降解性差(如骨水泥)或无法承受生理负荷(如水凝胶)的问题。在目前的方案中,我们将开发第二代PolyHIPE,它利用羟基磷灰石(HA)纳米颗粒来赋予骨移植骨诱导特性。我们还将研究在固化前将细胞包裹在HIPE中作为一种在缺损处传递和保留MSCs的方法的可能性。具体目的1:在含纳米羟基磷灰石的聚HIPE支架上建立和鉴定成骨细胞分化的特性;具体目标2:评价可注射的聚HIPE支架的关键部署变量和包裹后hMSCs的活性。随着R21项目的成功完成,建议的移植物将是骨移植程序的重大进步,因为它提供了一种高度多孔的支架,1)填充不规则形状的缺损区,促进良好的组织整合;2)治愈到合适的机械强度;3)将hMSCs直接输送到缺损处;以及4)为这些hMSCs的成骨分化提供必要的线索。随后的R01研究将检验这些骨诱导移植物在临界大小的骨缺损中促进再生的潜力,并对大型骨移植中的成骨和血管形成提供扩展的机制研究。
英文摘要
DESCRIPTION (provided by applicant): Musculoskeletal injuries have an enormous impact on quality of life and remain one of the leading reasons that patients seek medical care. Engineered tissue grafts have the potential to repair damaged tissues when traditional transplants are unavailable or fail. Our laboratory has developed a novel emulsion templating methodology to generate microcellular polymer scaffolds for bone regeneration. A significant advance by our laboratory is the translation of this technology to tissue engineering through the development of injectable, high porosity bone grafts. Injectable scaffolds that cure in situ can fil irregular shaped defects, improve contact between the scaffold and surrounding tissue, and eliminate the need for costly molding techniques.13,14 Emulsion templating has several advantages over current injectable materials that suffer from low porosity and biodegradability (e.g., bone cements) or inability to withstand physiological loading (e.g., hydrogels). In the current proposal, we will develop a second generation polyHIPE that utilize hydroxyapatite (HA) nanoparticles to impart osteoiductive character to the bone graft. We will also investigate the potential of cell encapsulation in the HIPEs prior to cure as a means to deliver and retain MSCs at the defect site. Specific Aim 1: Develop and characterize osteoblastic differentiation on polyHIPE scaffolds containing HA nanoparticles Specific Aim 2: Evaluate key deployment variables of injectable polyHIPE scaffolds and viability of hMSCs after encapsulation. Following successful completion of this R21 project, the proposed grafts will be a significant advance in bone grafting procedures by providing a highly porous scaffold that 1) space-fills irregular shaped defects to promote superior tissue integration; 2) cures to suitable mechanical strength; 3) delivers hMSCs directly to the defect site; and 4) provides the necessary cues for osteogenic differentiation of those hMSCs. Subsequent investigation in an R01 will examine the potential of these osteoinductive grafts to enhance regeneration in critical size bone defects and provide expanded mechanistic studies of osteogenesis and vascularization in large bone grafts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Injectable Hydrogel Electrodes to Prevent Ventricular Arrhythmias
-
批准号:10583238
-
项目类别:
-
资助金额:$56.19万
-
财政年份:2023
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
Resorbable, Shape Memory Stents to Prevent Vaginal Fibrosis
-
批准号:10301291
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2021
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
Resorbable, Shape Memory Stents to Prevent Vaginal Fibrosis
-
批准号:10454348
-
项目类别:
-
资助金额:$24.93万
-
财政年份:2021
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
In situ BMSC Seeding of 3D Printed Scaffolds Using Cell-releasing Hydrogels
-
批准号:10030953
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2020
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
In situ BMSC Seeding of 3D Printed Scaffolds Using Cell-releasing Hydrogels
-
批准号:10210190
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2020
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
EFFECT OF IMPROVED GRAFT COMPLIANCE MATCHING ON INTIMAL HYPERPLASIA
-
批准号:8954134
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2015
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
MULTILAYER VASCULAR GRAFTS BASED ON COLLAGEN-MIMETIC HYDROGELS
-
批准号:8447429
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2012
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
MULTILAYER VASCULAR GRAFTS BASED ON COLLAGEN-MIMETIC HYDROGELS
-
批准号:8604392
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2012
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
MULTILAYER VASCULAR GRAFTS BASED ON COLLAGEN-MIMETIC HYDROGELS
-
批准号:8302864
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2012
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
Injectable, High Porosity Bone Scaffolds by Emulsion Templating
-
批准号:7990644
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2010
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
Injectable, High Porosity Bone Scaffolds by Emulsion Templating
-
批准号:8097536
-
项目类别:
-
资助金额:$15.26万
-
财政年份:2010
-
负责人:Elizabeth Marie Cosgriff-Hernandez
-
依托单位:
海外基金